Ancillary Educational Events

Dissecting The Decision: Investigators Discuss the Available Data and Clinical Factors that Shape the Management of Gastrointestinal Cancers

Date and Time: Thursday, January 19, 7:15 PM

Location: San Francisco Marriott Marquis, Golden Gate Ballroom, B2 Level

CME Provider and Supporter(s): This event is organized and accredited by Research To Practice and is supported by educational grants provided by Bayer HealthCare Pharmaceuticals, Boston Biomedical Pharma Inc, Celgene Corporation, Genentech BioOncology, Halozyme Therapeutics, Lilly, Merrimack Pharmaceuticals Inc and Taiho Oncology.

Registration and Contact Information: Register for the event. Email for additional information or call (800)-233-6153.

Event Summary: Six investigators will serve as faculty, and prior to the event, Research To Practice (RTP) will recruit five community oncologists to provide challenging cases of patients with advanced colorectal, gastric, pancreatic and hepatocellular cancer. The agenda will be divided into six modules for which cases were ascertained, and the faculty will complete a pre-meeting survey to provide recommendations for each case. All responses will be graphically depicted and interspersed throughout the live event. Attendees will use iPads to complete a similar survey and the results will be juxtaposed with the faculty’s to illustrate any knowledge and practice gaps. Following the case discussions for each module, a faculty member will briefly review emerging research and ongoing trials. Clinicians will also use the iPads to submit their own questions and cases, and the meeting moderator, RTP president Dr. Neil Love, will present specific queries to the panelists to foster additional discussion.

Faculty
Tanios Bekaii-­Saab, MD 
Mayo Clinic AZ

Johanna C. Bendell, MD
Sarah Cannon Research Institute

John L. Marshall, MD
Lombardi Comprehensive Cancer Center, Georgetown University

Mary F. Mulcahy, MD
Northwestern University Feindberg School of Medicine

Phlip A. Philip, MD, PhD
Wayne State University

Bert H. O'Neil
Indiana University Simon Cancer Center

Eric Van Cutsem, MD, PhD
University Hospital Gasthuisberg/Leuven

Neil Love, MD—Moderator
Research To Practice

Evolution of the Treatment Algorithm for Carcinoid Syndrome

Date and Time: Thursday, January 19, 7:15 PM

Location: San Francisco Marriott Marquis, Yerba Buena Ballroom, Salon 7

CME Provider and Supporter(s): This event is organized and accredited by prIME Oncology, LLC, and is supported by an educational grant provided by Lexicon Pharmaceuticals, Inc.

Registration and Contact Information: Register for the event. For any additional information, email Emily Simpson.

Event Summary: Recently, an improved understanding of carcinoid neuroendocrine tumor cell biology has encouraged development of novel targeted therapies. In this symposium, the rationale of inhibiting molecules like tryptophan hydroxylase to suppress peripheral hormone synthesis will be presented. This will facilitate a discussion of results of recent and ongoing clinical trials, such as the TELECAST and TELESTAR trials. Other targeted therapies that can provide control of tumor bulk will also be discussed, with particular focus on the design and results of the NETTER-1 and RADIANT trials. Finally, the faculty will offer insight into how the discussed investigational agents might fit into the future treatment algorithm of carcinoid syndrome. 

Faculty

Emily K. Bergsland, MD
University of California, San Francisco

Matthew H. Kulke, MD- Chair
Dana-Farber Cancer Institute

Thomas O’Dorisio, MD
University of Iowa

Marianne Pavel, MD
Charité University Medicine Berlin 

The Dawn of Immunotherapy in Gastric and Colorectal Cancers

Date and Time: Friday, January 20, 7:15 PM

Location: San Francisco Marriott Marquis, Yerba Buena Ballroom, Salon 7, Lower B2 Level

CME Provider and Supporter(s): This event is organized and accredited by prIME Oncology, LLC, and is supported by an educational grant provided by Merck and Co, Inc.

Registration and Contact Information: Register for the event. For any additional information, email Emily Simpson.

Event Summary:This symposium will describe the molecular basis for immunotherapy in cancers and evidence supporting the theory that gastric cancer and colorectal cancer (CRC) are immunogenic. It will feature a discussion on the need for biomarkers of response to immunotherapy as well as unique aspects of response assessment and adverse event profiles of immunotherapeutic agents. Inherent immunogenicity of MMR-deficient CRC will be described, and recent and ongoing trials will be discussed. Strategies to enhance immune responses in gastric cancer and CRC will be highlighted, including combinations of immunotherapeutic agents with each other, as well as combinations with targeted agents or chemotherapy.

Faculty

Richard Goldberg, MD
West Virginia University

A. Craig Lockhart, MD, MHS
Washington University

Bert O’Neil, MD
Indiana University

Alan Venook, MD- Chair
University of California San Francisco